key: cord-0817193-t98s4xhd authors: Hasan, M. J.; Chowdhury, S. M.; Khan, M. A. S.; Rahaman, M.; Fardous, J.; Adit, T.; Rahman, M.; Hossain, M. T.; Yesmin, S.; Raheem, E.; Amin, M. R. title: Clinico-epidemiological characteristics of asymptomatic and symptomatic COVID-19-positive patients in Bangladesh date: 2020-08-21 journal: nan DOI: 10.1101/2020.08.18.20177089 sha: d4b006bfe19ac50c7b71d185f37ee105dab07359 doc_id: 817193 cord_uid: t98s4xhd Background: As of August 15, 2020, Bangladesh lost 3591 lives since the first Coronavirus disease 2019 (COVID-19) case announced on March 8. The objective of the study was to report the clinical manifestation of both symptomatic and asymptomatic COVID-19-positive patients. Methods: A online-based cross-sectional survey was conducted for initial recruitment of participants with subsequent telephone interview by the three trained physicians in 237 adults with confirmed COVID-19 infection in Bangladesh. The study period was between 27 April to 26th May, 2020. Consent was ensured before commencing the interview. Collected data were entered in a predesigned case report form and subsequently analyzed by SPSS 20. Results: The mean age at presentation was 41.59 (13.73 SD) years and most of the cases were male (73%). A total of 90.29% of patients reside in urban areas. Among the positive cases, 13.1% (n=31) were asymptomatic. Asymptomatic cases were significantly more common in households with 2 to 4 members (p=.008). Both symptomatic and asymptomatic patients shared similar ages of presentation (p=0.23), gender differences (p=0.30), and comorbidities (p=0.11). Only 5.3% of patients received ICU care during their treatment. The most frequent presentation was fever (88.3%), followed by cough (69.9%), chest pain (34.5%), body ache (31.1%), and sore throat (30.1%). Thirty-nine percent (n=92) of the patients had comorbidities, with diabetes and hypertension being the most frequently observed. Conclusion: There has been an upsurge in COVID-19 cases in Bangladesh. Patients were mostly middle-aged and male. Typical presentations were fever and cough. Maintenance of social distancing and increased testing are required to meet the current public health challenge. The earlier clinical spectrum of COVID-19 was dominated by fever, cough, and shortness of breath 5 . Dyspnea, headache, myalgia, rhinorrhea, sore throat, nausea, and vomiting were also reported in a number of cases 6, 7 . In addition to respiratory symptoms, neurological 8 , gastrointestinal 9 , cardiovascular 10 , musculoskeletal 11 , and other systematic presentations have also been reported 6 . It affects all ages, genders, and occupations, especially healthcare workers and family members, with COVID-19 positive cases 3, [12] [13] [14] [15] . Data up to this day have proven that higher chronological age and presence of comorbidities are the two most common underlying factors responsible for worse outcome 16, 17 . Diagnosis mostly depends on clinical symptoms and signs and subsequent investigations 18 . However, there is increasing evidence that many patients with COVID-19 are asymptomatic or have fewer symptoms to be recognized. The reported prevalence of asymptomatic patients ranged from 1% to 19 .2% 19, 20 . Unfortunately, asymptomatic cases can transmit the virus to others, consequently acting as a silent harbor of the infection 19 . The previous reports have shown that this virus was isolated from asymptomatic individuals, and the infections had been . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted August 21, 2020. . https://doi.org/10.1101/2020.08.18.20177089 doi: medRxiv preprint transmitted from asymptomatic patients 21 . As there are difficulties in screening for asymptomatic infections, it is difficult for national prevention and control of this epidemic unless appropriately addressed. Before that, it is essential to know the detailed picture and differences of both symptomatic and asymptomatic COVID-19 patients' characteristics and clinical manifestations (if present). As there are limited comparative data on the individuals with symptomatic and asymptomatic COVID-19, this study was conducted to assess the clinico-epidemiological profile of asymptomatic and symptomatic COVID-19-positive patients in Bangladesh. These data would help set effective preventive, and control strategies against this severe public health threat. The first three COVID-19 cases were reported by the Institute of Epidemiology, Disease Control and Research (IEDCR) at 8 th March 2020 3 . Since then, the spread of COVID-19 has increased exponentially along with panic. On 26 March 2020, the Government of the People's Republic of Bangladesh declared general holidays (or lock-down) for 10 days, later extended up to 30 May 2020 to curb the spread of the novel coronavirus in the country 22 . Due to nationwide lock-down, health center-based data collection or community-based national sampling surveys were not feasible. Hence, an online-based cross-sectional survey method was adopted. The study was conducted for the period of 26 April to 27 May 2020. A total of 376 responses were received, and among them, 237 confirmed COVID-19 cases were interviewed. Details of the patient selection are mentioned in Figure 1 . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted August 21, 2020. . https://doi.org/10.1101/2020.08.18.20177089 doi: medRxiv preprint Case excluded (n=13) due to under age . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted August 21, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 21, 2020. A total of 237 were finally included in the analysis. Of them, 13.1% (n=31) were asymptomatic ( Figure 2 ). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 21, 2020. . https://doi.org/10.1101/2020.08.18.20177089 doi: medRxiv preprint The mean age of the presentation of asymptomatic cases was slightly lower than that of symptomatic cases (39 vs. 41 years; p=.26). Both males and females are equally affected by the disease (p=.48) and predominately resided in urban areas. Asymptomatic cases were mostly observed in the house where 2-4 people lived within the same household. Twenty-six percent of the asymptomatic and forty-one percent of symptomatic cases had at least one comorbid disease. Among them, diabetes mellitus and hypertension were most frequently observed in both groups. More details about the socio-demographic profile are shown in table 1. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 21, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 21, 2020. . Among symptomatic COVID-19 patients, the average duration of illness was nine days, ranging from 6 to 21 days. Fever was the most common symptom (88.3%;182/206), followed by cough (69.9%; 144/206) and chest pain (34.5%, 71/206). Intensive care support was warranted in 5.3% of cases (11/206) . The detailed clinical characteristics of symptomatic patients are shown in Table 2 . Data is expressed as frequency (percentage); *Multiple responses considered Discussion: . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 21, 2020. However, our findings might not be an accurate approximation of the asymptomatic individuals in the general population, as asymptomatic infections were identified from those who were at high risk for infection (including close contacts or had a history of travel to hotspot zones) and not from a random sample of people. Therefore, the prevalence of asymptomatic infections needs . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 21, 2020. . https://doi.org/10.1101/2020.08.18.20177089 doi: medRxiv preprint to be evaluated through population screening 29 . Additionally, the proportion of asymptomatic infections might be even higher, as some cases might be missed by RT-PCR testing. Long et al. found seven asymptomatic patients with COVID-19 infection with negative RT-PCR results 30 . We found an overall male (73%) predominance without any significant difference between symptomatic and asymptomatic groups (p>0.05). However, previous studies found that asymptomatic infection is not limited to young or middle-aged adults 31 but also infants 31 , children 32 , and even the elderly 33 . In addition, asymptomatic infections were found in both males 34 and females 21 . Interestingly, in our study, asymptomatic cases were significantly higher compared to symptomatic cases in the house where 2-4 people lived within the same household (67.7% vs. 8.3%, p= .008). No other evidence is available to explain the findings and needs to be investigated further. Among the symptomatic cases, the majority had one or more symptoms. The most prevalent presentation was fever followed in decreasing order by cough, chest pain, body ache, sore throat, and breathlessness. These pattern of symptoms are consistent with the findings of other studies 3536, 37 . The initial studies in China 35, 36, 38, 39 also found predominant presentation of fever and cough among COVID-19 patients, which appears to be more common in adults than children, as well as breathlessness, and body ache, among other clinical features. A meta-analysis of Rodriguez et al found a similar frequency of fever in COVID-19 with SARS and MERS, but the cough frequency was higher in COVID-19 than MERS (< 50%) 36 We found a lower proportion of symptomatic patients with complaints about hyposmia (7.3%) compared to other studies where the proportion are relatively large 19, 38, 40 . These could be explained by the underreporting status of the patients or all of the patients may not be aware about the symptoms, or due to stuffy nose or runny nose patients may assume that it is usual . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 21, 2020. . https://doi.org/10.1101/2020.08.18.20177089 doi: medRxiv preprint consequences of stuffy nose rather a specific feature of COVID-19. Therefore, further studies are needed to determine the accuracy of this symptom in diagnosing COVID-19 and to determine whether this distinctive symptom is associated with nasal congestion or dysfunction of the olfactory nerve due to COVID-19 or other comorbidities 19 . However, headache, fatigue, nausea and/or vomiting, diarrhea, runny nose, stuffy nose, conjunctivitis, and oral ulcer were also found in small proportions in this study. Nevertheless, we should not underestimate these symptoms for the diagnostic purpose of COVID-19. This study has several limitations. There was an oversampling of a particular network of peers (e.g., socially engaged), leading to selection bias. As a result, the conclusion is less generalizable to the entire population, particularly for less educated people. More detailed patient information, particularly clinical outcomes and detailed investigations, was unavailable. The scope of confirmation of the data regarding comorbid conditions was minimal. Therefore, our findings on the symptoms of individuals with COVID-19 should be considered with caution. In conclusion, much attention should be given to identifying asymptomatic patients to reduce the transmission of SARS-CoV-2, as their potential to spread the virus cannot be misjudged. If both asymptomatic and symptomatic COVID-19 patients can be appropriately quarantined, community and family clustered transmission may be greatly reduced. Contact tracing and testing of the suspected case could be another strategy for preventing and controlling the disease. We have summarized the clinical and epidemic characteristics of both symptomatic and asymptomatic patients with COVID-19 with severe limitations. This deserves further study in . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 21, 2020. . outpatient, primary care, or community settings to obtain a full picture of the spectrum of the clinical scenario. The data in this study permit an early assessment of the epidemiological and clinical characteristics of Bangladesh's COVID19 cases. Furthermore, these data could be used in future planning and implementation of prevention and control strategies. The authors declare that there are no conflicts of interest regarding the publication of this paper. Ethical measures were taken throughout the study period to maintain a high standard of confidentiality and anonymity of the participants. Formal ethical clearance was taken from the ethical review committee of the Biomedical Research Foundation (BRF) for conducting the study, and formal permission was taken from the responders through Google form. All authors agree to publish the article. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted August 21, 2020. . https://doi.org/10.1101/2020.08.18.20177089 doi: medRxiv preprint Case excluded (n=13) due to under age . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted August 21, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted August 21, 2020. . https://doi.org/10.1101/2020.08.18.20177089 doi: medRxiv preprint A novel coronavirus from patients with pneumonia in China Coronavirus disease (COVID-19) pandemic Disease Control and Research (IEDCR)Institute of Epidemiology DC and R (IEDCR) Coronavirus disease (COVID-2019) Bangladesh situation reports-19 Clinical features of patients infected with 2019 novel coronavirus in Wuhan Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) COVID-19 in patients with rheumatic disease in Hubei province , China : a multicentre retrospective observational study Epidemiology Based on Current Evidence Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan Sex-based differences in susceptibility to SARS-CoV infection Clinical characteristics of COVID-19 in children compared with adults in Shandong Province Risk Factors and Outcomes Among the First Consecutive Patients Diagnosed with COVID-19: The Kuwait Experience Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area The epidemiology, diagnosis and treatment of COVID-19 Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19 Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Presumed Asymptomatic Carrier Transmission of COVID-19 The Financial Express. Decision on coronavirus lockdown restrictions Thursday. 2020 Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease Asymptomatic and Symptomatic Patients With Non-severe Coronavirus Disease (COVID-19) Have Similar Clinical Features and Virological Courses: A Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis Spread of SARS-CoV-2 in the Icelandic population Antibody responses to SARS-CoV-2 in patients with COVID-19 A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis A Review of Coronavirus Disease-2019 (COVID-19) Clinical features of patients infected with 2019 novel coronavirus in Wuhan Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia Sudden hyposmia as a prevalent symptom of COVID-19 infection